F19.28
Other psychoactive substance dependence with other psychoactive substance-induced disorders
Clinical Classification Guidelines
Medical Intelligence & Overview
ICD-10 code F19.28 refers to a condition where an individual is dependent on multiple psychoactive substances, and this dependence is accompanied by other substance-induced mental or physical disorders. This condition highlights the complexity of substance use disorders, especially when several substances are involved, and additional complications arise due to their combined effects. Recognizing this diagnosis can assist healthcare providers in developing comprehensive treatment plans tailored to manage both the dependence and the secondary disorders.
Causes & Symptoms
Clinical Causes: Repeated and prolonged use of multiple psychoactive substances, such as alcohol, opioids, stimulants, or sedatives. Psychological factors like stress, mental health disorders, or environmental influences that encourage substance use. Genetic predispositions affecting how the body processes certain substances or susceptibility to addiction. Certain social circumstances, including peer pressure or availability of substances, can facilitate poly-substance dependence. Chronic use leading to physical changes in the brain, reinforcing dependence and behavioral patterns.
Key Symptoms: Craving or a strong desire to use multiple psychoactive substances. Loss of control over substance use, leading to unsuccessful efforts to cut down or stop. Neglect of social, occupational, or recreational activities due to substance use. Development of tolerance, requiring increased amounts of substances to achieve the same effect. Withdrawal symptoms when not using the substances, such as irritability, tremors, or insomnia. Mental health issues like anxiety, depression, or paranoia that may be exacerbated by substance use. Physical health problems related to the substances used, such as liver disease, cardiovascular issues, or neurological impairments. Unusual behavior or mood swings linked to substance effects or withdrawal.
Diagnostic & Treatment
Diagnosis Path: Diagnosis typically involves a comprehensive assessment by a healthcare professional, including a detailed history of substance use, physical examinations, and mental health evaluations. Blood, urine, or hair tests can be used to detect the presence of various substances. Mental health assessments help identify any additional disorders induced or exacerbated by substance use. The diagnosis aligns with ICD-10 criteria for dependence and additional substance-related disorders.
Treatment Protocols: Treating this condition often requires a multidisciplinary approach that may include behavioral therapies, medication-assisted treatment, and support groups. The goal is to manage dependence on multiple substances while addressing other induced disorders. Strategies can include: - Detoxification to safely manage withdrawal symptoms. - Counseling or psychotherapy to modify harmful behaviors and address underlying psychological factors. - Medications to reduce cravings or manage withdrawal symptoms. - Long-term relapse prevention programs, emphasizing ongoing support. - Comorbid mental health treatment if necessary. Effective treatment plans are typically individualized to suit the specific substances involved and the severity of dependence, as well as co-occurring disorders.
Clinical Advice & FAQs
Billing Guidance
Is F19.28 a billable ICD-10 code?
Yes, F19.28 is a specific, billable code that can be used to indicate a diagnosis for reimbursement purposes.
Documentation
How do I report F19.28?
Clinical documentation must specify the nature of Other psychoactive substance dependence with other psychoactive substance-induced disorders and any associated comorbidities for accurate reporting.
Cite this Clinical Reference
